
1. annu rev med. 1984;35:279-91.

acyclovir chemotherapy herpes group viral infections.

balfour hh jr.

the recent profusion antiviral research resulted significant advances
toward prevention treatment herpes group virus infections. most
promising new agent acyclovir, available topical, intravenous, and
oral formulations. results clinical trials acyclovir prevention and
treatment herpes simplex, varicella-zoster virus, cytomegalovirus, and
epstein-barr virus infections discussed, potential problem of
antiviral resistance considered. vidarabine therapy reviewed briefly, and
future new drugs activity herpesviruses mentioned.

doi: 10.1146/annurev.me.35.020184.001431 
pmid: 6326661  [indexed medline]

